Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Northrop Grumman to Host Virtual Annual Shareholders Meeting
-
Logansport Financial Corp. Announces Second Quarter Dividend
-
X4 Pharmaceuticals Announces Upcoming Presentation of Phase 2 Chronic Neutropenia Trial Data at the 30th Annual EHA Congress
-
Boston Omaha Corporation Announces First Quarter 2025 Financial Results
-
Dominican Government and DP World Announce Historic US$760 Million Investment to Expand Free Zone and Port Capacity
-
Forian Inc. Announces First Quarter 2025 Financial Results
-
Grove Announces First Quarter 2025 Financial Results
-
GENFIT: Publication of the 2025 Extra-Financial Performance Report (fiscal year 2024)
-
Canaan Inc. Provides April 2025 Bitcoin Production and Mining Operation Updates
-
Boot Barn Holdings, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results and $200 Million Share Repurchase Program
-
Alto Neuroscience Reports First Quarter 2025 Financial Results and Recent Business Highlights
-
Caring Cross and HIEx Launch Advanced Therapies Investment Platform to Expand Affordable Care for Cancer, Sickle Cell Disease, and Other Chronic Global Diseases in Low- and Middle-Income Countries
-
Aardvark Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights
-
Acrivon Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights
-
GENFIT: Publication of the 2025 Extra-Financial Performance Report (fiscal year 2024)
-
USA Rare Earth Reports its First Quarter 2025 Financial Results
-
IREN Reports Q3 FY25 Results
-
Lightwave Logic Appoints Robert Blum as Senior Vice President of Sales and Marketing
-
Harte Hanks Reports First Quarter 2025 Results
-
Aytu BioPharma Reports Fiscal 2025 Third Quarter Operational and Financial Results
-
MARPAI REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS
-
Spruce Power Reports First Quarter 2025 Results
-
Spire Global Selected for U.S. Space Force Contract with $237 Million Ceiling
-
Silo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel Intranasal PTSD Therapy, SPC-15
-
Intelligent Protection Management Corp. Reports First Quarter 2025 Financial Results Reflecting Transition to Managed Technology Solutions Provider Focused on Cybersecurity and Cloud Infrastructure
-
The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance
-
Fossil Group, Inc. Reports First Quarter 2025 Financial Results
-
Hawkins, Inc. Reports Fourth Quarter and Fiscal Year 2025 Results
-
Castor Maritime Inc. Reports Fourth Quarter and Full Year Results for 2024
-
Lulus Reports First Quarter 2025 Results
-
Tectonic Financial Appoints David Clifford as President; Michelle Baird as Chief Financial Officer
-
Shimmick Corporation Announces First Quarter 2025 Results
-
Sol-Ark Powers Ethiopia's First K-12 STEM School With Solar Energy
-
Electrovaya Reports Q2 Fiscal Year 2025 Results
-
Tortoise Capital Announces Closed-End Fund Distributions
-
CV Sciences, Inc. Reports First Quarter 2025 Financial Results
-
Bannix Acquisition Corp. Announces Monthly Extension to Complete its Initial Business Combination
-
Castor Maritime Inc. Announces Availability of its 2024 Annual Report on Form 20-F
-
Aterian Reports 2025 First Quarter Financial Results
-
The Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical Officer
-
Shimmick Corporation Announces First Quarter 2025 Results
-
Alumis Reports First Quarter 2025 Financial Results and Highlights Recent Achievements
-
BioCardia Reports First Quarter 2025 Business Highlights and Financial Results
-
SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates
-
Rekor Systems Reports First Quarter 2025 Financial Results
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2025
-
eGain Announces Third Quarter 2025 Financial Results
-
Inseego to Participate in TD Cowen and Stifel Investor Conferences
-
Toro Corp. Announces Full Repayment of the Senior Term Loan Granted to Castor Maritime Inc.
-
Zentalis Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Progress

